8-K

CRH PUBLIC LTD CO 8-K Report (Mar 12, 2021)

Filed March 12, 2021For Securities:CRH

Summary

This SEC filing (Form 6-K) from CRH Public Limited Company, filed on March 11, 2021, discloses transactions involving ordinary shares by individuals in managerial positions. Specifically, it details share awards, vesting, and sales by Albert Manifold (Chief Executive), Senan Murphy (Finance Director), and Neil Colgan (Company Secretary). These transactions occurred on March 9, 2021, and provide insight into the compensation and executive stock holdings within the company. For investors, this filing primarily serves as a transparency mechanism regarding insider stock activity. It shows that senior executives are receiving share-based compensation, with awards granted under the company's 2014 Performance Share Plan and Deferred Share Bonus Plan. The report also indicates that these executives are selling some of their shares, which could be interpreted in various ways, but is a common practice for diversification and personal financial management. The prices at which shares were acquired and sold offer a glimpse into the market value of CRH shares around that period.

Key Highlights

  • 1Disclosure of share transactions by key CRH executives: Albert Manifold (CEO), Senan Murphy (Finance Director), and Neil Colgan (Company Secretary).
  • 2Transactions include the grant of deferred share awards and performance share awards under CRH's 2014 plans.
  • 3Vesting of previously granted deferred share awards and performance share awards also occurred.
  • 4Executives engaged in the sale of CRH ordinary shares, with sales prices noted.
  • 5The transactions took place on March 9, 2021, and were reported on March 11, 2021.
  • 6Details provided for each transaction include the number of ordinary shares and, where applicable, the price per share.
  • 7Neil Colgan also reported a transfer of shares to his spouse.

Frequently Asked Questions

This filing (Form 6-K) is a regulatory disclosure required under EU market abuse regulations to report transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. It provides transparency regarding insider trading of CRH ordinary shares.

The filing reports several types of transactions, including: 1) Deferred Share Awards, 2) Grants of awards under the 2014 Performance Share Plan, 3) Acquisition of shares under employee share participation schemes, 4) Release of Deferred Share Awards, 5) Vesting of Performance Share Plan Awards, and 6) Sale of shares. There was also a transfer of shares to a spouse.

Albert Manifold sold 37,500 shares at €39.87 and 86,503 shares at an average price of €39.595. Senan Murphy sold 24,553 shares at an average price of €39.595. These figures represent the sales of shares by these executives at prices close to the market rate at the time.

These transactions primarily reflect executive compensation and personal financial planning. Executives often receive shares as part of their compensation and may sell them for diversification, tax planning, or other personal reasons. While a sale of shares by an executive can sometimes be interpreted negatively, it is a common practice and does not necessarily signal a negative outlook on the company's future performance. Investors should consider these transactions in the broader context of the company's financial health and strategic initiatives.